Applied Clinical Trials October Recap
Our October issue focused on the current state of outsourcing with additional coverage around site networks and risk-based quality management.
This October, Applied Clinical Trials focused on the topic of new-age outsourcing. Led by the rise of integrated research organizations (IROs), providers are finding new and innovative ways to design their trials. In the case of IROs, this new approach enhances diversity and access by bringing clinical trials directly to patient communities, as opposed to more traditional research sites.
On the business side of outsourcing, partnering with a functional service provider (FSP) is becoming critical. These providers are now supporting sponsors through oversight and leveraging business operations data, giving those who partner with them a clear edge in trial execution.
In addition to the current outsourcing landscape, ACT’s October issue also provided key insights on site networks and risk-based quality management (RBQM).
With November on the horizon, the following slideshow provides a look back at the previously mentioned topics we covered in October.
Image Credit: © Lucas - stock.adobe.com
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
